| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stomach | 34 | 2025 | 265 | 10.160 |
Why?
|
| Chief Cells, Gastric | 24 | 2024 | 24 | 6.350 |
Why?
|
| Gastric Mucosa | 39 | 2025 | 485 | 5.880 |
Why?
|
| Cell Plasticity | 11 | 2022 | 36 | 5.290 |
Why?
|
| Cell Differentiation | 31 | 2025 | 1849 | 4.560 |
Why?
|
| Metaplasia | 38 | 2024 | 213 | 4.040 |
Why?
|
| Stomach Neoplasms | 22 | 2024 | 565 | 4.000 |
Why?
|
| Parietal Cells, Gastric | 18 | 2023 | 33 | 3.850 |
Why?
|
| Stem Cells | 18 | 2024 | 676 | 2.580 |
Why?
|
| Regeneration | 7 | 2024 | 205 | 2.280 |
Why?
|
| Epithelial Cells | 14 | 2021 | 869 | 2.250 |
Why?
|
| Barrett Esophagus | 5 | 2025 | 346 | 2.190 |
Why?
|
| Cellular Reprogramming | 7 | 2021 | 107 | 2.020 |
Why?
|
| Cell Proliferation | 16 | 2023 | 2389 | 1.960 |
Why?
|
| Organoids | 6 | 2025 | 280 | 1.830 |
Why?
|
| Animals | 95 | 2025 | 33120 | 1.800 |
Why?
|
| Esophageal Neoplasms | 4 | 2025 | 371 | 1.740 |
Why?
|
| Precancerous Conditions | 9 | 2024 | 277 | 1.650 |
Why?
|
| Carcinogenesis | 8 | 2024 | 343 | 1.580 |
Why?
|
| Tamoxifen | 8 | 2019 | 344 | 1.550 |
Why?
|
| Mice | 71 | 2025 | 17585 | 1.460 |
Why?
|
| Cell Cycle | 6 | 2021 | 585 | 1.450 |
Why?
|
| Cell Transdifferentiation | 7 | 2021 | 59 | 1.330 |
Why?
|
| Adenocarcinoma | 8 | 2025 | 976 | 1.270 |
Why?
|
| Cell Transformation, Neoplastic | 8 | 2024 | 606 | 1.210 |
Why?
|
| Transcription Factors | 11 | 2021 | 2341 | 1.190 |
Why?
|
| Helicobacter Infections | 12 | 2021 | 1268 | 1.180 |
Why?
|
| Homeostasis | 8 | 2025 | 686 | 1.180 |
Why?
|
| Intestines | 5 | 2024 | 578 | 1.100 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2025 | 165 | 1.090 |
Why?
|
| Cell Lineage | 12 | 2022 | 323 | 1.020 |
Why?
|
| Apoptosis | 5 | 2025 | 1805 | 1.010 |
Why?
|
| SOXB1 Transcription Factors | 2 | 2025 | 57 | 1.000 |
Why?
|
| Wound Healing | 4 | 2022 | 444 | 0.970 |
Why?
|
| Mice, Knockout | 21 | 2025 | 3706 | 0.960 |
Why?
|
| Esophageal Mucosa | 1 | 2025 | 12 | 0.930 |
Why?
|
| Fibroblast Growth Factor 9 | 1 | 2025 | 9 | 0.920 |
Why?
|
| Organelle Biogenesis | 1 | 2025 | 19 | 0.920 |
Why?
|
| Skin | 2 | 2018 | 515 | 0.910 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 4 | 2024 | 167 | 0.890 |
Why?
|
| Ribosomes | 1 | 2025 | 123 | 0.870 |
Why?
|
| Pancreas | 4 | 2023 | 215 | 0.860 |
Why?
|
| Cell Division | 6 | 2020 | 719 | 0.850 |
Why?
|
| Neoplasms | 4 | 2024 | 2848 | 0.850 |
Why?
|
| Pancreatic Neoplasms | 4 | 2025 | 710 | 0.850 |
Why?
|
| Fibroblast Growth Factors | 1 | 2025 | 162 | 0.830 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2025 | 726 | 0.830 |
Why?
|
| Autophagosomes | 2 | 2020 | 27 | 0.820 |
Why?
|
| Helicobacter pylori | 9 | 2020 | 1326 | 0.820 |
Why?
|
| Gastrointestinal Tract | 3 | 2018 | 218 | 0.800 |
Why?
|
| Paneth Cells | 2 | 2020 | 20 | 0.790 |
Why?
|
| Gastritis | 8 | 2021 | 371 | 0.780 |
Why?
|
| Humans | 73 | 2025 | 126089 | 0.770 |
Why?
|
| ErbB Receptors | 1 | 2024 | 285 | 0.760 |
Why?
|
| Acinar Cells | 5 | 2025 | 10 | 0.740 |
Why?
|
| Single-Cell Analysis | 3 | 2024 | 317 | 0.740 |
Why?
|
| Maturation-Promoting Factor | 1 | 2021 | 9 | 0.740 |
Why?
|
| rab GTP-Binding Proteins | 2 | 2014 | 49 | 0.720 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2021 | 32 | 0.720 |
Why?
|
| Intestinal Mucosa | 6 | 2021 | 754 | 0.710 |
Why?
|
| Oligosaccharides | 1 | 2021 | 73 | 0.700 |
Why?
|
| Resin Cements | 1 | 2021 | 4 | 0.700 |
Why?
|
| Membrane Proteins | 3 | 2021 | 1568 | 0.680 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2021 | 86 | 0.680 |
Why?
|
| Gastric Acid | 2 | 2018 | 50 | 0.670 |
Why?
|
| Neoplasm Proteins | 2 | 2021 | 653 | 0.670 |
Why?
|
| Viral Tropism | 1 | 2021 | 41 | 0.670 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2015 | 576 | 0.660 |
Why?
|
| Lysosomes | 3 | 2021 | 248 | 0.650 |
Why?
|
| Epithelium | 4 | 2022 | 335 | 0.640 |
Why?
|
| Esophagus | 2 | 2018 | 229 | 0.630 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 2 | 2016 | 27 | 0.620 |
Why?
|
| Peptides | 9 | 2018 | 828 | 0.620 |
Why?
|
| Gene Expression Regulation | 7 | 2022 | 2313 | 0.610 |
Why?
|
| Gene Expression Profiling | 10 | 2024 | 1763 | 0.610 |
Why?
|
| Mice, Inbred C57BL | 17 | 2024 | 4496 | 0.600 |
Why?
|
| Interferon-gamma | 3 | 2019 | 518 | 0.590 |
Why?
|
| Gastroenterology | 2 | 2018 | 216 | 0.570 |
Why?
|
| Metformin | 1 | 2020 | 157 | 0.560 |
Why?
|
| Terminology as Topic | 1 | 2019 | 222 | 0.550 |
Why?
|
| Physiological Phenomena | 1 | 2017 | 2 | 0.520 |
Why?
|
| Secretory Pathway | 1 | 2017 | 10 | 0.520 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2017 | 30 | 0.520 |
Why?
|
| Cell Separation | 2 | 2015 | 219 | 0.510 |
Why?
|
| Antibodies, Monoclonal | 2 | 2021 | 987 | 0.500 |
Why?
|
| Atrophy | 6 | 2020 | 236 | 0.480 |
Why?
|
| CD13 Antigens | 1 | 2015 | 10 | 0.480 |
Why?
|
| Calcium | 3 | 2019 | 1031 | 0.470 |
Why?
|
| Biomedical Research | 2 | 2018 | 527 | 0.460 |
Why?
|
| Integrases | 3 | 2011 | 153 | 0.460 |
Why?
|
| Immunohistochemistry | 9 | 2021 | 1596 | 0.460 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 9 | 2024 | 284 | 0.440 |
Why?
|
| Mitochondria | 3 | 2024 | 731 | 0.430 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2025 | 973 | 0.430 |
Why?
|
| Plasma Cells | 2 | 2012 | 53 | 0.420 |
Why?
|
| Secretory Vesicles | 2 | 2010 | 20 | 0.400 |
Why?
|
| Pseudogenes | 1 | 2013 | 50 | 0.400 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 588 | 0.400 |
Why?
|
| Carrier Proteins | 4 | 2020 | 1011 | 0.400 |
Why?
|
| Hyaluronan Receptors | 1 | 2013 | 64 | 0.400 |
Why?
|
| Selection, Genetic | 1 | 2013 | 161 | 0.380 |
Why?
|
| Amino Acid Transport System y+ | 2 | 2024 | 8 | 0.370 |
Why?
|
| Trefoil Factor-2 | 5 | 2019 | 9 | 0.360 |
Why?
|
| DNA-Binding Proteins | 5 | 2016 | 1886 | 0.360 |
Why?
|
| Organelles | 1 | 2011 | 21 | 0.360 |
Why?
|
| Genetic Loci | 1 | 2013 | 342 | 0.360 |
Why?
|
| Gastrointestinal Diseases | 2 | 2017 | 336 | 0.360 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2011 | 52 | 0.350 |
Why?
|
| Gastritis, Atrophic | 2 | 2024 | 61 | 0.350 |
Why?
|
| Mice, Transgenic | 15 | 2022 | 2311 | 0.350 |
Why?
|
| rab3 GTP-Binding Proteins | 2 | 2014 | 7 | 0.350 |
Why?
|
| Endoplasmic Reticulum, Rough | 1 | 2010 | 2 | 0.340 |
Why?
|
| Heat-Shock Proteins | 1 | 2011 | 176 | 0.340 |
Why?
|
| Biomarkers, Tumor | 4 | 2021 | 1559 | 0.330 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2013 | 350 | 0.330 |
Why?
|
| X-Box Binding Protein 1 | 4 | 2016 | 24 | 0.330 |
Why?
|
| SOX9 Transcription Factor | 2 | 2023 | 86 | 0.320 |
Why?
|
| Stomach Ulcer | 2 | 2021 | 92 | 0.320 |
Why?
|
| Evolution, Molecular | 1 | 2013 | 683 | 0.310 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2011 | 192 | 0.310 |
Why?
|
| RNA-Binding Proteins | 4 | 2023 | 534 | 0.310 |
Why?
|
| Models, Biological | 8 | 2009 | 1370 | 0.300 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2 | 2024 | 43 | 0.300 |
Why?
|
| Signal Transduction | 9 | 2024 | 4468 | 0.300 |
Why?
|
| Morphogenesis | 1 | 2010 | 192 | 0.300 |
Why?
|
| Disease Models, Animal | 13 | 2024 | 4409 | 0.300 |
Why?
|
| Cell Line | 5 | 2019 | 2565 | 0.290 |
Why?
|
| Stem Cell Niche | 1 | 2008 | 57 | 0.290 |
Why?
|
| Neoplastic Stem Cells | 1 | 2010 | 331 | 0.280 |
Why?
|
| Azetidines | 2 | 2019 | 63 | 0.280 |
Why?
|
| Colonic Neoplasms | 2 | 2023 | 251 | 0.280 |
Why?
|
| Adult Stem Cells | 1 | 2008 | 52 | 0.270 |
Why?
|
| Protein Transport | 4 | 2014 | 350 | 0.270 |
Why?
|
| Phenotype | 6 | 2017 | 4304 | 0.260 |
Why?
|
| CDX2 Transcription Factor | 2 | 2025 | 11 | 0.260 |
Why?
|
| Transcription, Genetic | 5 | 2016 | 1378 | 0.260 |
Why?
|
| Embryonic Stem Cells | 3 | 2017 | 161 | 0.250 |
Why?
|
| Binding Sites | 3 | 2016 | 1187 | 0.250 |
Why?
|
| Hyperplasia | 2 | 2021 | 186 | 0.250 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2025 | 169 | 0.250 |
Why?
|
| Cytoplasmic Granules | 1 | 2007 | 50 | 0.250 |
Why?
|
| Piperazines | 2 | 2019 | 250 | 0.250 |
Why?
|
| Databases, Protein | 1 | 2006 | 59 | 0.240 |
Why?
|
| Drosophila Proteins | 1 | 2011 | 756 | 0.240 |
Why?
|
| Intestine, Small | 3 | 2024 | 286 | 0.240 |
Why?
|
| Alleles | 1 | 2010 | 1611 | 0.230 |
Why?
|
| Natural Language Processing | 1 | 2006 | 71 | 0.230 |
Why?
|
| Antibodies | 2 | 2021 | 351 | 0.230 |
Why?
|
| User-Computer Interface | 1 | 2006 | 155 | 0.230 |
Why?
|
| Promoter Regions, Genetic | 3 | 2016 | 1207 | 0.230 |
Why?
|
| Pancreatitis | 2 | 2023 | 137 | 0.230 |
Why?
|
| Interleukins | 2 | 2020 | 119 | 0.220 |
Why?
|
| Mice, Inbred BALB C | 3 | 2019 | 987 | 0.220 |
Why?
|
| Organ Specificity | 3 | 2018 | 396 | 0.220 |
Why?
|
| Cell Line, Tumor | 3 | 2021 | 3483 | 0.220 |
Why?
|
| Autoimmune Diseases | 2 | 2020 | 269 | 0.220 |
Why?
|
| Cells, Cultured | 8 | 2015 | 2902 | 0.220 |
Why?
|
| Chitinases | 1 | 2024 | 4 | 0.210 |
Why?
|
| Swine Diseases | 1 | 2024 | 40 | 0.210 |
Why?
|
| Pluripotent Stem Cells | 3 | 2017 | 70 | 0.210 |
Why?
|
| Ascaris suum | 1 | 2024 | 32 | 0.210 |
Why?
|
| Reactive Oxygen Species | 2 | 2024 | 494 | 0.200 |
Why?
|
| Regulatory Factor X Transcription Factors | 3 | 2016 | 10 | 0.200 |
Why?
|
| Ascariasis | 1 | 2024 | 73 | 0.200 |
Why?
|
| Repressor Proteins | 3 | 2020 | 762 | 0.200 |
Why?
|
| Diphtheria Toxin | 3 | 2016 | 14 | 0.190 |
Why?
|
| RNA Editing | 2 | 2022 | 35 | 0.190 |
Why?
|
| Doxorubicin | 1 | 2024 | 286 | 0.190 |
Why?
|
| Disease Progression | 2 | 2019 | 2099 | 0.190 |
Why?
|
| Peritoneal Neoplasms | 1 | 2023 | 53 | 0.190 |
Why?
|
| Proteins | 2 | 2014 | 1015 | 0.180 |
Why?
|
| Pancreas, Exocrine | 1 | 2021 | 5 | 0.180 |
Why?
|
| Software | 2 | 2006 | 711 | 0.180 |
Why?
|
| Microscopy, Confocal | 3 | 2013 | 360 | 0.180 |
Why?
|
| Cell Polarity | 3 | 2013 | 116 | 0.180 |
Why?
|
| Adenosine Deaminase | 1 | 2022 | 90 | 0.180 |
Why?
|
| Pancreatic Ducts | 1 | 2021 | 20 | 0.180 |
Why?
|
| RNA, Double-Stranded | 1 | 2022 | 59 | 0.180 |
Why?
|
| CD36 Antigens | 1 | 2021 | 33 | 0.180 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2021 | 5 | 0.180 |
Why?
|
| Gene Expression | 3 | 2018 | 1485 | 0.180 |
Why?
|
| Species Specificity | 2 | 2013 | 519 | 0.180 |
Why?
|
| Endosomes | 1 | 2021 | 62 | 0.180 |
Why?
|
| Antibody Specificity | 1 | 2021 | 196 | 0.180 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2014 | 298 | 0.180 |
Why?
|
| Colitis | 1 | 2023 | 157 | 0.180 |
Why?
|
| Adenocarcinoma in Situ | 1 | 2021 | 1 | 0.170 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2020 | 479 | 0.170 |
Why?
|
| Base Sequence | 4 | 2018 | 2770 | 0.170 |
Why?
|
| Gene Deletion | 2 | 2017 | 768 | 0.170 |
Why?
|
| Interleukin-33 | 1 | 2020 | 17 | 0.170 |
Why?
|
| Genomics | 1 | 2009 | 1571 | 0.170 |
Why?
|
| Sequence Analysis, RNA | 1 | 2024 | 417 | 0.170 |
Why?
|
| Licensure | 1 | 2020 | 12 | 0.170 |
Why?
|
| Ileitis | 1 | 2020 | 10 | 0.160 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2010 | 130 | 0.160 |
Why?
|
| Lung Diseases | 1 | 2024 | 392 | 0.160 |
Why?
|
| Serine Endopeptidases | 1 | 2021 | 191 | 0.160 |
Why?
|
| Cell Growth Processes | 1 | 2019 | 60 | 0.160 |
Why?
|
| Plastics | 1 | 2019 | 12 | 0.160 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2019 | 412 | 0.160 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2021 | 223 | 0.160 |
Why?
|
| Urinary Bladder | 2 | 2012 | 247 | 0.150 |
Why?
|
| Sulfasalazine | 1 | 2019 | 4 | 0.150 |
Why?
|
| RNA, Messenger | 8 | 2023 | 2547 | 0.150 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 269 | 0.150 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 276 | 0.150 |
Why?
|
| Regenerative Medicine | 1 | 2019 | 35 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2020 | 192 | 0.150 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 9 | 2012 | 1002 | 0.150 |
Why?
|
| Catheter Ablation | 1 | 2022 | 304 | 0.150 |
Why?
|
| Intrinsic Factor | 2 | 2016 | 2 | 0.150 |
Why?
|
| Genotype | 2 | 2016 | 2600 | 0.150 |
Why?
|
| Fatty Liver | 1 | 2021 | 204 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2013 | 1225 | 0.150 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 169 | 0.150 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2018 | 23 | 0.150 |
Why?
|
| Cell Dedifferentiation | 1 | 2018 | 20 | 0.140 |
Why?
|
| Female | 17 | 2022 | 67915 | 0.140 |
Why?
|
| Enterotoxigenic Escherichia coli | 1 | 2018 | 6 | 0.140 |
Why?
|
| In Situ Hybridization | 3 | 2010 | 450 | 0.140 |
Why?
|
| Congresses as Topic | 1 | 2019 | 173 | 0.140 |
Why?
|
| Clonal Evolution | 1 | 2018 | 46 | 0.140 |
Why?
|
| Salivary Proteins and Peptides | 1 | 2018 | 18 | 0.140 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2018 | 5 | 0.140 |
Why?
|
| Bacterial Proteins | 3 | 2020 | 908 | 0.140 |
Why?
|
| Cell Death | 1 | 2019 | 236 | 0.140 |
Why?
|
| Research Support as Topic | 1 | 2018 | 59 | 0.140 |
Why?
|
| Bacterial Adhesion | 1 | 2018 | 101 | 0.140 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2018 | 37 | 0.140 |
Why?
|
| S Phase | 1 | 2018 | 71 | 0.140 |
Why?
|
| Computational Biology | 4 | 2013 | 839 | 0.140 |
Why?
|
| Environment | 1 | 2018 | 146 | 0.130 |
Why?
|
| Immediate-Early Proteins | 1 | 2017 | 57 | 0.130 |
Why?
|
| Fluorouracil | 1 | 2017 | 133 | 0.130 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2012 | 500 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 985 | 0.130 |
Why?
|
| Ectopic Gene Expression | 1 | 2017 | 2 | 0.130 |
Why?
|
| Plant Lectins | 1 | 2016 | 4 | 0.130 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 2016 | 16 | 0.130 |
Why?
|
| Flow Cytometry | 4 | 2013 | 758 | 0.130 |
Why?
|
| Gastrectomy | 1 | 2017 | 98 | 0.130 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2022 | 743 | 0.130 |
Why?
|
| Biomarkers | 4 | 2024 | 3138 | 0.120 |
Why?
|
| Time Factors | 3 | 2017 | 6016 | 0.120 |
Why?
|
| Prostheses and Implants | 1 | 2017 | 144 | 0.120 |
Why?
|
| Male | 13 | 2022 | 62089 | 0.120 |
Why?
|
| Adult | 6 | 2024 | 30254 | 0.120 |
Why?
|
| Injections | 1 | 2016 | 112 | 0.120 |
Why?
|
| Gastrula | 2 | 2012 | 22 | 0.120 |
Why?
|
| Sorting Nexins | 1 | 2015 | 8 | 0.120 |
Why?
|
| Immunity, Innate | 1 | 2018 | 394 | 0.120 |
Why?
|
| Osteopetrosis | 1 | 2015 | 12 | 0.120 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2017 | 253 | 0.110 |
Why?
|
| Microtubules | 2 | 2013 | 118 | 0.110 |
Why?
|
| Myelin and Lymphocyte-Associated Proteolipid Proteins | 1 | 2014 | 2 | 0.110 |
Why?
|
| Osteoclasts | 1 | 2015 | 64 | 0.110 |
Why?
|
| Syndecan-1 | 2 | 2012 | 7 | 0.110 |
Why?
|
| Mitosis | 1 | 2015 | 190 | 0.110 |
Why?
|
| Lac Operon | 2 | 2011 | 90 | 0.110 |
Why?
|
| Insulin-Secreting Cells | 1 | 2016 | 132 | 0.110 |
Why?
|
| DNA Primers | 2 | 2013 | 602 | 0.110 |
Why?
|
| Mutation | 3 | 2019 | 5926 | 0.110 |
Why?
|
| Transfection | 1 | 2016 | 947 | 0.110 |
Why?
|
| Colon | 2 | 2009 | 353 | 0.110 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2014 | 15 | 0.110 |
Why?
|
| Risk Factors | 3 | 2018 | 10397 | 0.100 |
Why?
|
| Liver Cirrhosis | 1 | 2021 | 876 | 0.100 |
Why?
|
| Inflammation | 2 | 2013 | 1418 | 0.100 |
Why?
|
| STAT3 Transcription Factor | 2 | 2013 | 215 | 0.100 |
Why?
|
| DNA | 2 | 2009 | 1422 | 0.100 |
Why?
|
| Cell Enlargement | 1 | 2013 | 6 | 0.100 |
Why?
|
| Death-Associated Protein Kinases | 1 | 2013 | 3 | 0.100 |
Why?
|
| H(+)-K(+)-Exchanging ATPase | 1 | 2013 | 7 | 0.100 |
Why?
|
| Likelihood Functions | 1 | 2013 | 111 | 0.100 |
Why?
|
| Amino Acid Sequence | 2 | 2015 | 2544 | 0.100 |
Why?
|
| Protamines | 1 | 2012 | 12 | 0.100 |
Why?
|
| Sus scrofa | 1 | 2013 | 114 | 0.100 |
Why?
|
| Visceral Pain | 1 | 2012 | 7 | 0.100 |
Why?
|
| Intestinal Neoplasms | 1 | 2013 | 36 | 0.100 |
Why?
|
| Myelopoiesis | 1 | 2012 | 12 | 0.100 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2013 | 103 | 0.100 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2012 | 15 | 0.100 |
Why?
|
| Microarray Analysis | 1 | 2013 | 224 | 0.100 |
Why?
|
| Point Mutation | 1 | 2014 | 336 | 0.100 |
Why?
|
| Bone Density | 1 | 2015 | 351 | 0.100 |
Why?
|
| Conserved Sequence | 1 | 2013 | 284 | 0.090 |
Why?
|
| Genetics, Population | 1 | 2013 | 191 | 0.090 |
Why?
|
| Macrophages | 3 | 2023 | 638 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 727 | 0.090 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 162 | 0.090 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2013 | 111 | 0.090 |
Why?
|
| Regression Analysis | 1 | 2013 | 757 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2013 | 1014 | 0.090 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2013 | 458 | 0.090 |
Why?
|
| Macaca mulatta | 1 | 2013 | 480 | 0.090 |
Why?
|
| Prognosis | 2 | 2018 | 4709 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 968 | 0.090 |
Why?
|
| Cell Compartmentation | 1 | 2011 | 37 | 0.090 |
Why?
|
| Injections, Intraperitoneal | 1 | 2011 | 66 | 0.090 |
Why?
|
| Haplotypes | 1 | 2013 | 528 | 0.090 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 301 | 0.090 |
Why?
|
| Mesoderm | 3 | 2010 | 104 | 0.090 |
Why?
|
| Leukemia, Plasma Cell | 1 | 2010 | 5 | 0.090 |
Why?
|
| Endothelial Cells | 2 | 2021 | 505 | 0.090 |
Why?
|
| Phylogeny | 1 | 2013 | 719 | 0.080 |
Why?
|
| Intracellular Membranes | 1 | 2010 | 55 | 0.080 |
Why?
|
| Aged | 6 | 2023 | 20005 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2013 | 1189 | 0.080 |
Why?
|
| Incidence | 1 | 2018 | 3213 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 1350 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 1350 | 0.080 |
Why?
|
| Tissue Array Analysis | 1 | 2010 | 135 | 0.080 |
Why?
|
| Embryo, Nonmammalian | 1 | 2010 | 137 | 0.080 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2010 | 31 | 0.080 |
Why?
|
| Models, Genetic | 1 | 2013 | 744 | 0.080 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 413 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2010 | 200 | 0.080 |
Why?
|
| Nuclear Proteins | 3 | 2014 | 1205 | 0.080 |
Why?
|
| Immune Evasion | 1 | 2009 | 37 | 0.080 |
Why?
|
| Lymphoma | 1 | 2012 | 319 | 0.080 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 2009 | 13 | 0.080 |
Why?
|
| Body Patterning | 1 | 2010 | 129 | 0.080 |
Why?
|
| Administration, Oral | 1 | 2011 | 666 | 0.080 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2009 | 36 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2009 | 10 | 0.080 |
Why?
|
| Cell Cycle Proteins | 2 | 2010 | 676 | 0.080 |
Why?
|
| Lipopolysaccharides | 1 | 2010 | 292 | 0.080 |
Why?
|
| Chronic Disease | 3 | 2020 | 1187 | 0.080 |
Why?
|
| Cecum | 1 | 2009 | 26 | 0.070 |
Why?
|
| Carcinoma | 1 | 2011 | 279 | 0.070 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2012 | 286 | 0.070 |
Why?
|
| Interleukin-17 | 1 | 2009 | 125 | 0.070 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 3599 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2010 | 581 | 0.070 |
Why?
|
| Transgenes | 1 | 2010 | 330 | 0.070 |
Why?
|
| Intercellular Junctions | 1 | 2008 | 25 | 0.070 |
Why?
|
| Urothelium | 1 | 2009 | 59 | 0.070 |
Why?
|
| Tretinoin | 1 | 2009 | 94 | 0.070 |
Why?
|
| Gene Knockout Techniques | 2 | 2019 | 131 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 6552 | 0.070 |
Why?
|
| Enterocytes | 1 | 2009 | 65 | 0.070 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2009 | 200 | 0.070 |
Why?
|
| Immunity, Mucosal | 1 | 2008 | 83 | 0.070 |
Why?
|
| Gastric Fundus | 1 | 2007 | 9 | 0.070 |
Why?
|
| Islets of Langerhans | 1 | 2008 | 146 | 0.070 |
Why?
|
| Mucins | 1 | 2007 | 67 | 0.070 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2009 | 222 | 0.070 |
Why?
|
| Cadherins | 1 | 2008 | 174 | 0.070 |
Why?
|
| Expressed Sequence Tags | 2 | 2006 | 79 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3256 | 0.070 |
Why?
|
| Escherichia coli Infections | 1 | 2009 | 183 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 678 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 1 | 2008 | 273 | 0.070 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2009 | 219 | 0.070 |
Why?
|
| DNA Damage | 1 | 2010 | 492 | 0.070 |
Why?
|
| Mucus | 1 | 2007 | 37 | 0.060 |
Why?
|
| Extracellular Fluid | 1 | 2006 | 12 | 0.060 |
Why?
|
| Dendritic Cells | 1 | 2009 | 435 | 0.060 |
Why?
|
| GATA2 Transcription Factor | 1 | 2006 | 46 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 1593 | 0.060 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2006 | 87 | 0.060 |
Why?
|
| Vocabulary, Controlled | 1 | 2006 | 11 | 0.060 |
Why?
|
| Killer Cells, Natural | 1 | 2008 | 334 | 0.060 |
Why?
|
| Middle Aged | 5 | 2022 | 27331 | 0.060 |
Why?
|
| Computer Graphics | 1 | 2006 | 37 | 0.060 |
Why?
|
| Database Management Systems | 1 | 2006 | 28 | 0.060 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2006 | 125 | 0.060 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2009 | 253 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2008 | 449 | 0.060 |
Why?
|
| Drosophila melanogaster | 1 | 2011 | 816 | 0.060 |
Why?
|
| Information Storage and Retrieval | 1 | 2006 | 62 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 235 | 0.060 |
Why?
|
| Amyloid beta-Peptides | 1 | 2006 | 225 | 0.060 |
Why?
|
| DNA Repair | 1 | 2008 | 550 | 0.060 |
Why?
|
| Muscle Proteins | 1 | 2007 | 397 | 0.060 |
Why?
|
| RNA | 1 | 2008 | 519 | 0.060 |
Why?
|
| Protein Binding | 1 | 2008 | 1661 | 0.050 |
Why?
|
| Ascaris | 1 | 2024 | 10 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 2750 | 0.050 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2004 | 84 | 0.050 |
Why?
|
| Host-Pathogen Interactions | 2 | 2018 | 252 | 0.050 |
Why?
|
| DNA Adducts | 1 | 2024 | 71 | 0.050 |
Why?
|
| Astrocytes | 1 | 2006 | 260 | 0.050 |
Why?
|
| Lectins | 1 | 2003 | 48 | 0.050 |
Why?
|
| Escherichia coli | 1 | 2009 | 962 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2019 | 826 | 0.050 |
Why?
|
| Capillaries | 1 | 2003 | 68 | 0.050 |
Why?
|
| Neuroendocrine Tumors | 1 | 2004 | 58 | 0.050 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2024 | 101 | 0.050 |
Why?
|
| Larva | 1 | 2024 | 253 | 0.050 |
Why?
|
| Peritoneum | 1 | 2023 | 37 | 0.050 |
Why?
|
| Microcirculation | 1 | 2003 | 108 | 0.050 |
Why?
|
| Mammals | 1 | 2024 | 250 | 0.050 |
Why?
|
| Fasting | 1 | 2024 | 300 | 0.050 |
Why?
|
| Ascites | 1 | 2023 | 98 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 1 | 2003 | 233 | 0.050 |
Why?
|
| Peptide Fragments | 2 | 2003 | 745 | 0.050 |
Why?
|
| Artificial Intelligence | 1 | 2006 | 296 | 0.050 |
Why?
|
| Glycolysis | 1 | 2002 | 167 | 0.050 |
Why?
|
| Mucin 5AC | 1 | 2021 | 21 | 0.050 |
Why?
|
| Neurons | 2 | 2009 | 1919 | 0.050 |
Why?
|
| Enteroendocrine Cells | 1 | 2021 | 18 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2002 | 250 | 0.050 |
Why?
|
| Fibrosis | 1 | 2023 | 398 | 0.040 |
Why?
|
| Endoderm | 2 | 2012 | 23 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2002 | 266 | 0.040 |
Why?
|
| Esophagoscopy | 1 | 2022 | 164 | 0.040 |
Why?
|
| Algorithms | 1 | 2008 | 1619 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 2582 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2008 | 825 | 0.040 |
Why?
|
| Swine | 1 | 2024 | 1164 | 0.040 |
Why?
|
| Receptors, Cytokine | 1 | 2020 | 64 | 0.040 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2020 | 37 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2002 | 554 | 0.040 |
Why?
|
| Organophosphorus Compounds | 1 | 2020 | 25 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2021 | 257 | 0.040 |
Why?
|
| Bromodeoxyuridine | 1 | 2019 | 56 | 0.040 |
Why?
|
| Eosinophils | 1 | 2020 | 122 | 0.040 |
Why?
|
| Young Adult | 1 | 2013 | 9616 | 0.040 |
Why?
|
| APOBEC-1 Deaminase | 1 | 2018 | 11 | 0.040 |
Why?
|
| Lewis X Antigen | 1 | 2018 | 11 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 2936 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2023 | 754 | 0.040 |
Why?
|
| Fimbriae Proteins | 1 | 2018 | 20 | 0.040 |
Why?
|
| Adhesins, Bacterial | 1 | 2018 | 70 | 0.040 |
Why?
|
| Precision Medicine | 1 | 2021 | 344 | 0.040 |
Why?
|
| Piperidines | 1 | 2020 | 224 | 0.040 |
Why?
|
| Caco-2 Cells | 1 | 2018 | 86 | 0.030 |
Why?
|
| Adoptive Transfer | 2 | 2009 | 230 | 0.030 |
Why?
|
| Interleukin-10 | 2 | 2009 | 180 | 0.030 |
Why?
|
| Insulin | 2 | 2016 | 1131 | 0.030 |
Why?
|
| Missouri | 1 | 2017 | 41 | 0.030 |
Why?
|
| Membrane Glycoproteins | 2 | 2013 | 415 | 0.030 |
Why?
|
| Antigens, Differentiation | 2 | 2009 | 63 | 0.030 |
Why?
|
| Lasers | 2 | 2008 | 107 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2020 | 1293 | 0.030 |
Why?
|
| Toll-Like Receptors | 2 | 2008 | 80 | 0.030 |
Why?
|
| Lung | 1 | 2024 | 1519 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 2029 | 0.030 |
Why?
|
| Calcium Gluconate | 1 | 2015 | 5 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2016 | 202 | 0.030 |
Why?
|
| Pepsinogen C | 1 | 2014 | 10 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2014 | 25 | 0.030 |
Why?
|
| Endocytosis | 1 | 2015 | 120 | 0.030 |
Why?
|
| Vitamin D Deficiency | 1 | 2015 | 71 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 372 | 0.030 |
Why?
|
| Gene Library | 2 | 2006 | 212 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 2006 | 435 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2013 | 73 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2016 | 769 | 0.030 |
Why?
|
| Genomic Islands | 1 | 2013 | 30 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2017 | 726 | 0.020 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2012 | 17 | 0.020 |
Why?
|
| Calgranulin A | 1 | 2012 | 5 | 0.020 |
Why?
|
| Mice, Congenic | 1 | 2012 | 16 | 0.020 |
Why?
|
| Lymphopoiesis | 1 | 2012 | 9 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 236 | 0.020 |
Why?
|
| Urinary Bladder Diseases | 1 | 2012 | 33 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2013 | 229 | 0.020 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 199 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2012 | 291 | 0.020 |
Why?
|
| Glucose | 1 | 2016 | 842 | 0.020 |
Why?
|
| Liver | 1 | 2018 | 1764 | 0.020 |
Why?
|
| Helicobacter felis | 1 | 2010 | 2 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2013 | 373 | 0.020 |
Why?
|
| Xenopus | 1 | 2010 | 103 | 0.020 |
Why?
|
| Xenopus Proteins | 1 | 2010 | 59 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 523 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 229 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 2772 | 0.020 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2009 | 39 | 0.020 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2009 | 53 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2009 | 59 | 0.020 |
Why?
|
| Telencephalon | 1 | 2009 | 10 | 0.020 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2009 | 16 | 0.020 |
Why?
|
| Transferrin | 1 | 2009 | 45 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2009 | 87 | 0.020 |
Why?
|
| Serum Albumin, Bovine | 1 | 2009 | 52 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 538 | 0.020 |
Why?
|
| Microdissection | 1 | 2008 | 13 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2010 | 212 | 0.020 |
Why?
|
| Receptors, CCR6 | 1 | 2008 | 6 | 0.020 |
Why?
|
| CD56 Antigen | 1 | 2008 | 26 | 0.020 |
Why?
|
| Interleukin-23 | 1 | 2008 | 15 | 0.020 |
Why?
|
| Chemokine CCL20 | 1 | 2008 | 15 | 0.020 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2008 | 27 | 0.020 |
Why?
|
| Ulcer | 1 | 2009 | 49 | 0.020 |
Why?
|
| Palatine Tonsil | 1 | 2008 | 35 | 0.020 |
Why?
|
| Virulence | 1 | 2009 | 264 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2009 | 227 | 0.020 |
Why?
|
| Rhombencephalon | 1 | 2009 | 57 | 0.020 |
Why?
|
| Culture Media | 1 | 2009 | 170 | 0.020 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2009 | 92 | 0.020 |
Why?
|
| STAT1 Transcription Factor | 1 | 2008 | 69 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2009 | 273 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2008 | 288 | 0.020 |
Why?
|
| Epididymal Secretory Proteins | 1 | 2007 | 1 | 0.020 |
Why?
|
| Minichromosome Maintenance Complex Component 3 | 1 | 2007 | 1 | 0.020 |
Why?
|
| Fetal Proteins | 1 | 2007 | 10 | 0.020 |
Why?
|
| beta-Defensins | 1 | 2007 | 11 | 0.020 |
Why?
|
| Gastrins | 1 | 2007 | 30 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2008 | 298 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2009 | 167 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2009 | 244 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 2009 | 311 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2009 | 749 | 0.020 |
Why?
|
| Acute Disease | 1 | 2010 | 1046 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2008 | 567 | 0.020 |
Why?
|
| Ion Channels | 1 | 2009 | 200 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2009 | 672 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2009 | 323 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 363 | 0.020 |
Why?
|
| Erythroblasts | 1 | 2006 | 5 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2009 | 447 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2006 | 60 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2009 | 206 | 0.020 |
Why?
|
| Actins | 1 | 2009 | 311 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2006 | 66 | 0.020 |
Why?
|
| Monocytes | 1 | 2008 | 331 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2007 | 247 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2009 | 674 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 1354 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 1281 | 0.010 |
Why?
|
| Synapses | 1 | 2009 | 433 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2006 | 685 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 2004 | 118 | 0.010 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2004 | 94 | 0.010 |
Why?
|
| Child | 1 | 2024 | 25062 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 2004 | 190 | 0.010 |
Why?
|
| Genome | 1 | 2006 | 483 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 2003 | 46 | 0.010 |
Why?
|
| Germ-Free Life | 1 | 2003 | 60 | 0.010 |
Why?
|
| Databases as Topic | 1 | 2003 | 72 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2004 | 423 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 307 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2004 | 632 | 0.010 |
Why?
|
| United States | 1 | 2017 | 11204 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2003 | 192 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2004 | 1494 | 0.010 |
Why?
|